Skip to main content

Animations

MJFF Publications

5801 - 5810 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2014
  • 2010
  • 2022
  • 2017
  • 2021
  • 2021
  • 2020
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Five-Year Longitudinal Trajectories of Non-Motor Symptoms in Relation to Baseline Dopaminergic Decline in Parkinson’s Disease
    Journal Name: Brain Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.dscb.2025.100288
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Safety Study of Transcranial Static Magnetic Field Stimulation (tSMS) of the Human Cortex
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brs.2014.12.002
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2010.06.009
    Citation Count: 199
  • Summary Details
    OPEN
    Title: Designing the Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease study
    Journal Name: Contemporary Clinical Trials
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.cct.2022.106713
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Predicting behavioral variant frontotemporal dementia with pattern classification in multi-center structural MRI data
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nicl.2017.02.001
    Citation Count: 73
  • Summary Details
    OPEN
    Title: Systematic Assessment of 10 Biomarker Candidates Focusing on α‐Synuclein‐Related Disorders
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28738
    Citation Count: 84
  • Summary Details
    OPEN
    Title: Predicting optimal deep brain stimulation parameters for Parkinson’s disease using functional MRI and machine learning
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-23311-9
    Citation Count: 224
  • Summary Details
    OPEN
    Title: Towards defining reference materials for measuring extracellular vesicle refractive index, epitope abundance, size and concentration
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/20013078.2020.1816641
    Citation Count: 122
  • Summary Details
    OPEN
    Title: Crohn’s and Parkinson’s Disease-Associated LRRK2 Mutations Alter Type II Interferon Responses in Human CD14+ Blood Monocytes Ex Vivo
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s11481-020-09909-8
    Citation Count: 19
  • Summary Details
    OPEN
    Title: miEAA 2.0: integrating multi-species microRNA enrichment analysis and workflow management systems
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1093/nar/gkaa309
    Citation Count: 168
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.